PuraStat as secondary therapy for hemostasis in Mallory−Weiss syndrome with oral antithrombotic medication
2024

Using PuraStat for Bleeding in Mallory-Weiss Syndrome

publication Evidence: low

Author Information

Author(s): Higashino Makoto, Murakami Hidehiro, Hirata Tetsu, Miyaoka Hiroaki

Primary Institution: Saiseikai Matsuyama Hospital, Ehime, Japan

Hypothesis

Can PuraStat effectively achieve hemostasis in patients with Mallory-Weiss syndrome who are on antithrombotic medication?

Conclusion

PuraStat can achieve complete hemostasis in Mallory-Weiss syndrome when traditional methods fail.

Supporting Evidence

  • PuraStat has been used successfully in other types of gastrointestinal bleeding.
  • The patient had multiple lacerations and traditional methods did not achieve hemostasis.

Takeaway

If someone is bleeding in their stomach because of vomiting, PuraStat can help stop the bleeding when other methods don't work.

Methodology

A case report of a 67-year-old man treated with PuraStat after traditional methods failed to stop bleeding.

Limitations

This is a single case report, so broader conclusions cannot be drawn.

Participant Demographics

67-year-old man with a history of coronary artery bypass grafting and on antithrombotic medication.

Digital Object Identifier (DOI)

10.1002/deo2.70033

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication